4//SEC Filing
Hayes Christopher G. 4
Accession 0001209191-21-038481
CIK 0001660334other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 8:42 AM ET
Size
5.1 KB
Accession
0001209191-21-038481
Insider Transaction Report
Form 4
Hayes Christopher G.
CHIEF LEGAL OFFICER
Transactions
- Purchase
Common Stock
2021-06-04$9.79/sh+2,500$24,475→ 2,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.782 to $9.803 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001805359
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 8:42 AM ET
- Size
- 5.1 KB